Article Categories
Agricultural and Biological Sciences
Arts and Humanities
Biochemistry Genetics and Molecular Biology
Business, Management and Accounting
Chemical Engineering
Chemistry
Computer Science
Decision Sciences
Dentistry
Earth and Planetary Sciences
Economics, Econometrics and Finance
Energy
Engineering
Environmental Science
Health Professions
Immunology and Microbiology
Materials Science
Mathematics
Medicine
Neuroscience
Nursing
Pharmacology, Toxicology and Pharmaceutics
Physics and Astronomy
Psychology
Social Sciences
Veterinary
Browse Categories
Browse Drugs
Browse Journals
Search
Browse Categories
Browse Categories
Allergy and Immunology
Cardiology
Clinical Procedures
Critical Care
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology
Genomic Medicine
Hematology
Infectious Diseases
Nephrology
Neurology
Obstetrics and Gynecology
Oncology
Pathology
Perioperative Care
Physical & Rehabilitation
Psychiatry
Pulmonology
Radiology
Rheumatology
Sports Medicine
Browse Journals
Correction to GPR103 Antagonists Demonstrating Anorexigenic Activity in Vivo: Design and Development of Pyrrolo[2,3-c]pyridines That Mimic the C-Terminal Arg-Phe Motif of QRFP26.
Jennie Georgsson
,
Fredrik Bergström
,
Anneli Nordqvist
,
Martin J Watson
,
Charles D Blundell
,
Magnus J Johansson
,
Annika U Petersson
,
Zhong-Qing Yuan
,
Yiqun Zhou
,
Lisbeth Kristensson
,
Dorota Kakol-Palm
,
Christian Tyrchan
,
Eric Wellner
,
Udo Bauer
,
Peter Brodin
,
Anette Svensson Henriksson
J Med Chem
Published: May 2015
Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Download full-text PDF
Source
http://dx.doi.org/10.1021/acs.jmedchem.5b00479
DOI Listing
Publication Analysis
Top Keywords
correction gpr103
4
gpr103 antagonists
4
antagonists demonstrating
4
demonstrating anorexigenic
4
anorexigenic activity
4
activity vivo
4
vivo design
4
design development
4
development pyrrolo[23-c]pyridines
4
pyrrolo[23-c]pyridines mimic
4
Similar Publications
Privacy Policy
Site Map
Contact Us
© LitMetric 2025. All rights reserved.